Subject: Jeffrey S. Bland, PhD: " The Emerging Therapeutic Target"
Date: November 15, 2008 (8:30 am – 4:30 pm)
Venue:
Shangri-La’s Far Eastern Plaza Hotel
201 Tun Hwa South Road, Section 2
Taipei, Taiwan

Metagenics, Inc. was formed in 1983 as a life sciences company and the premier manufacturer of science-based medical foods and nutraceuticals marketed to healthcare professionals. As a leader in the fields of nutrigenomics and functional medicine, healthcare practitioners around the world rely on Metagenics’ products and services to help their patients achieve a lifetime of good health. Metagenics has its own R&D facilities with laboratory and manufacturing plants that allow them to develop and produce the finest products.

Jeffrey S. Bland, PhD, FACN, CNS Chief Science Officer of Metagenics, Inc. President of MetaProteomics, and Founder of Institute for Functional Medicine has been an internationally recognized leader in the nutritional medicine field for over 30 years.

At this seminar, Dr. Bland will explore the clinical and basic science that has led to the understanding of an intersection, or underlying physiological mechanism, associated with multiple chronic conditions, such as: Osteoporosis; Cardiovascular disease including cardio-metabolic syndrome; Type 2 diabetes; arthritis and other inflammatory conditions; and Insulin-medicated dementia. This revolutionary information provides the opportunity to address the therapeutic target – a cause rather than effect – of multiple chronic illnesses, enabling healthcare providers to achieve more effective clinical outcomes.

The American Institute in Taiwan Commercial Section on behalf of Metagenics Inc. and its Taiwan distributor Prisma Health Care Corporation invite your participation of a revolutionary clinical approach. Please complete and send the form below or fax to 886-2-2757-7162 Attention: Angeli Chou. The Prisma Health Care Corp. will send you a detailed registration form of this event.